Delivery Order SPE2DB22D2211-SPE2DB23FNGF0
Award Date
5/9/23
Potential Completion Date
5/10/23
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,750.34 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with an ultimate completion date of April 20, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,831.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RIZATRIPTAN 10 MG ODT UD 3S, a pharmaceutical product, with a completion date of May 5, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $18,100.85 firm fixed price delivery order contract to provide RIZATRIPTAN 5 MG ODT UD 3S, a pharmaceutical product, through January 31, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceuticals and medical supplies to DLA...
This federal contract award, valued at $1,436.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4565111851 - RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,020.31 firm fixed-price delivery order is for the supply of RIZATRIPTAN 10 MG ODT UD 18S, a pharmaceutical product. The contract has a ceiling value of $3,020.31 and an ultimate completion date of December 16, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime...
This federal contract award, valued at $2,629.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4560665789 RIZATRIPTAN 10 MG TABLET UD 18S, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,558.19, is a delivery order for the supply of RIZATRIPTAN 10 MG ODT UD 3S, a medication primarily used for the treatment of migraines. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,184.82 firm fixed-price delivery order is for the supply of 18 units of the drug Rizatriptan 10 mg Orally Disintegrating Tablets. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, worth $2,418.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order, is for the supply of Rizatriptan 5 mg orally disintegrating tablets. It is a firm-fixed-price contract with a performance period through May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $7,238.14, is for the delivery of 4564945122 RIZATRIPTAN 10 MG ODT UD 3S. It is a firm fixed-price contract with a completion date of June 20, 2024. Amerisourcebergen holds two larger indefinite delivery contracts (IDCs) with the...